83 FR 34589 - Agency Forms Undergoing Paperwork Reduction Act Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 83, Issue 140 (July 20, 2018)
Centers for Disease Control and Prevention
Federal Register Volume 83, Issue 140 (July 20, 2018)
| Page Range | 34589-34590 | |
| FR Document | 2018-15526 |
[Federal Register Volume 83, Number 140 (Friday, July 20, 2018)] [Notices] [Pages 34589-34590] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-15526] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day-18-1091] Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled ``Using Qualitative Methods to Understand Issues in HIV Prevention, Care and Treatment in the United States'' to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ``Proposed Data Collection Submitted for Public Comment and Recommendations'' notice on March 13, 2018 to obtain comments from the public and affected agencies. CDC received four comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639-7570 or send an email to [email protected]. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide written comments within 30 days of notice publication. Proposed Project Using Qualitative Methods to Understand Issues in HIV Prevention, Care and Treatment in the United States (OMB No. 0920-1091; expires December 31, 2018)--Extension--National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Background and Brief Description The CDC's National Center on HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP), Division of HIV/AIDS Prevention (DHAP) seeks a three year extension for an existing Generic information collection request (Generic ICR) entitled, ``Using Qualitative Methods to Understand Issues in HIV Prevention, Care and Treatment in the United States'' (OMB Number: 0920-1091). Specific studies conducted under this extended Generic ICR will be consistent with the national HIV prevention goals, the CDC Division of HIV/AIDS Prevention (DHAP) Strategic Plan, and DHAP's High-impact HIV Prevention approach. The purposes for each data collection study supported under this extended Generic ICR will be to understand specific barriers and facilitators to local HIV prevention, care and treatment in the United States and territories. For example, each study will seek to identify ways to improve programmatic activities along the continuum of HIV prevention, treatment and care for different populations residing in different geographic settings with greatest burden of HIV. The target populations for studies included in this extended Generic ICR include, but are not limited to: Persons living with HIV who are in treatment; persons living with HIV who are out of treatment and who may or may not be seeking treatment at healthcare facilities; persons at high risk for HIV acquisition (HIV negative) and HIV transmission (HIV positive); persons from groups at high risk for HIV including gay, bisexual and other MSM, transgender persons, and injection and non-injection drug users; persons from racial and ethnic minorities; and healthcare providers or other professionals who provide HIV prevention, care and treatment services. Other populations may include individuals who provide non-HIV services or otherwise interact with persons living with HIV or persons at risk for HIV acquisition. Studies will only provide local contextual information about the barriers and facilitators to HIV prevention, care, and treatment experienced by specific communities at risk for acquiring HIV infection, by HIV-positive persons across the HIV care continuum, and by organizations or individuals providing HIV prevention, care, treatment, and related support services. Data collection methods used in any of the specific studies primarily will consist of rapid qualitative assessment methodologies, such as semi-structured and in-depth qualitative interviews, focus groups; direct observations; document reviews; and short structured surveys. Data will be analyzed using [[Page 34590]] well-established qualitative analysis methods, such as coding interviews for themes about barriers and successes to HIV prevention, care, and treatment. Structured response surveys will be analyzed using descriptive statistics and other appropriate statistical methods. CDC will use the results from each specific data collection study to help to identify ways to improve local programmatic activities for specific communities along the continuum of HIV prevention, treatment and care for populations and areas with the greatest HIV burden. CDC will communicate study outcomes to local stakeholders and organizations in positions to consider and implement site-specific improvements in HIV prevention, care, and treatment for each of the study sites examined. For stakeholders, organizations, or agencies outside the local affected communities, all communications will include clear discussion of the limitations of the region-specific, qualitative methods and the non-generalizability of the study outcomes. For a given year, each separate data collection will range from 30 (minimum) to 200 (maximum) respondents based on the nature and scope of the research purposes. For example, if there are three data collections, the maximum combined number of expected respondents is 600. In a given year, CDC anticipates that the need to screen 1600 persons to identify 800 eligible persons, of which 600 persons will agree to participate. CDC anticipates that screener forms will take five minutes to complete each, contact information forms will take one minute to complete each, and consent forms will take five minutes to complete each. CDC anticipates 50% of the targeted populations screened will be eligible for the study. Of eligible persons, 75% will agree to participate. Brief structured surveys will take 15 minutes to complete. In-depth interviews or focus groups with respondents are expected to take 60 minutes (one hour) to complete. In-depth interviews or focus groups with healthcare providers are expected to take 45 minutes to complete. The total annual response burden based on an average of 600 study respondents per year (assuming three large data collections involving 200 participants each) is estimated at 918 hours. There is no cost to respondents other than their time. ---------------------------------------------------------------------------------------------------------------- Number of Average burden Type of respondents Form name Number of responses per per response respondents respondent (in hours) ---------------------------------------------------------------------------------------------------------------- General Public--Adults................ Study Screener.......... 1600 1 5/60 General Public--Adults................ Contact Information Form 600 1 1/60 General Public--Adults................ Consent Form............ 600 1 5/60 General Public--Adults................ Demographic Survey...... 500 1 15/60 General Public--Adults................ Interview Guide......... 500 1 1 General Public--Adults................ Provider Demographic 100 1 15/60 Survey. General Public--Adults................ Provider Interview Guide 100 1 45/60 ---------------------------------------------------------------------------------------------------------------- Jeffrey M. Zirger, Acting Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2018-15526 Filed 7-19-18; 8:45 am] BILLING CODE 4163-18-P
![Federal Register / Vol. 83, No. 140 / Friday, July 20, 2018 / Notices 34589
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per
Type of respondents Form name responses per
respondents response
respondent (in hours)
Patients aged 18 years or older ..................... Online surveys (18-month follow-up) ............. 960 1 7/60
Patients aged 18 years or older who com- Online surveys (30-month follow-up) ............. 660 1 10/60
pleted 18 mo survey.
Patients aged 18 years or older who did not Online surveys (30-month follow-up) ............. 220 1 10/60
complete 18 mo survey.
Jeffrey M. Zirger, (c) Enhance the quality, utility, and The purposes for each data collection
Acting Chief, Information Collection Review clarity of the information to be study supported under this extended
Office, Office of Scientific Integrity, Office collected; Generic ICR will be to understand
of the Associate Director for Science, Office (d) Minimize the burden of the specific barriers and facilitators to local
of the Director, Centers for Disease Control collection of information on those who HIV prevention, care and treatment in
and Prevention. are to respond, including, through the the United States and territories. For
[FR Doc. 2018–15524 Filed 7–19–18; 8:45 am] use of appropriate automated, example, each study will seek to
BILLING CODE 4163–18–P electronic, mechanical, or other identify ways to improve programmatic
technological collection techniques or activities along the continuum of HIV
other forms of information technology, prevention, treatment and care for
DEPARTMENT OF HEALTH AND e.g., permitting electronic submission of different populations residing in
HUMAN SERVICES responses; and different geographic settings with
(e) Assess information collection greatest burden of HIV.
Centers for Disease Control and costs.
Prevention The target populations for studies
To request additional information on included in this extended Generic ICR
[30Day–18–1091] the proposed project or to obtain a copy include, but are not limited to: Persons
of the information collection plan and living with HIV who are in treatment;
Agency Forms Undergoing Paperwork instruments, call (404) 639–7570 or persons living with HIV who are out of
Reduction Act Review send an email to omb@cdc.gov. Direct treatment and who may or may not be
written comments and/or suggestions
In accordance with the Paperwork seeking treatment at healthcare
regarding the items contained in this
Reduction Act of 1995, the Centers for facilities; persons at high risk for HIV
notice to the Attention: CDC Desk
Disease Control and Prevention (CDC) acquisition (HIV negative) and HIV
Officer, Office of Management and
has submitted the information transmission (HIV positive); persons
Budget, 725 17th Street NW,
collection request titled ‘‘Using from groups at high risk for HIV
Washington, DC 20503 or by fax to (202)
Qualitative Methods to Understand including gay, bisexual and other MSM,
395–5806. Provide written comments
Issues in HIV Prevention, Care and transgender persons, and injection and
within 30 days of notice publication.
Treatment in the United States’’ to the non-injection drug users; persons from
Office of Management and Budget Proposed Project racial and ethnic minorities; and
(OMB) for review and approval. CDC Using Qualitative Methods to healthcare providers or other
previously published a ‘‘Proposed Data Understand Issues in HIV Prevention, professionals who provide HIV
Collection Submitted for Public Care and Treatment in the United States prevention, care and treatment services.
Comment and Recommendations’’ (OMB No. 0920–1091; expires December Other populations may include
notice on March 13, 2018 to obtain 31, 2018)—Extension—National Center individuals who provide non-HIV
comments from the public and affected for HIV/AIDS, Viral Hepatitis, STD, and services or otherwise interact with
agencies. CDC received four comments TB Prevention, Centers for Disease persons living with HIV or persons at
related to the previous notice. This Control and Prevention (CDC). risk for HIV acquisition.
notice serves to allow an additional 30 Studies will only provide local
days for public and affected agency Background and Brief Description contextual information about the
comments. The CDC’s National Center on HIV/ barriers and facilitators to HIV
CDC will accept all comments for this AIDS, Viral Hepatitis, STD and TB prevention, care, and treatment
proposed information collection project. Prevention (NCHHSTP), Division of experienced by specific communities at
The Office of Management and Budget HIV/AIDS Prevention (DHAP) seeks a risk for acquiring HIV infection, by HIV-
is particularly interested in comments three year extension for an existing positive persons across the HIV care
that: Generic information collection request continuum, and by organizations or
(a) Evaluate whether the proposed (Generic ICR) entitled, ‘‘Using individuals providing HIV prevention,
collection of information is necessary Qualitative Methods to Understand care, treatment, and related support
for the proper performance of the Issues in HIV Prevention, Care and services.
functions of the agency, including Treatment in the United States’’ (OMB Data collection methods used in any
daltland on DSKBBV9HB2PROD with NOTICES
whether the information will have Number: 0920–1091). Specific studies of the specific studies primarily will
practical utility; conducted under this extended Generic consist of rapid qualitative assessment
(b) Evaluate the accuracy of the ICR will be consistent with the national methodologies, such as semi-structured
agencies estimate of the burden of the HIV prevention goals, the CDC Division and in-depth qualitative interviews,
proposed collection of information, of HIV/AIDS Prevention (DHAP) focus groups; direct observations;
including the validity of the Strategic Plan, and DHAP’s High-impact document reviews; and short structured
methodology and assumptions used; HIV Prevention approach. surveys. Data will be analyzed using
VerDate Sep<11>2014 18:06 Jul 19, 2018 Jkt 244001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\20JYN1.SGM 20JYN1](https://thefederalregister.org/doc/83_FR_34729/page/1.svg)
![34590 Federal Register / Vol. 83, No. 140 / Friday, July 20, 2018 / Notices
well-established qualitative analysis organizations, or agencies outside the minute to complete each, and consent
methods, such as coding interviews for local affected communities, all forms will take five minutes to complete
themes about barriers and successes to communications will include clear each. CDC anticipates 50% of the
HIV prevention, care, and treatment. discussion of the limitations of the targeted populations screened will be
Structured response surveys will be region-specific, qualitative methods and eligible for the study. Of eligible
analyzed using descriptive statistics and the non-generalizability of the study persons, 75% will agree to participate.
other appropriate statistical methods. outcomes. Brief structured surveys will take 15
For a given year, each separate data
CDC will use the results from each minutes to complete. In-depth
collection will range from 30
specific data collection study to help to interviews or focus groups with
(minimum) to 200 (maximum)
identify ways to improve local respondents are expected to take 60
respondents based on the nature and
programmatic activities for specific scope of the research purposes. For minutes (one hour) to complete. In-
communities along the continuum of example, if there are three data depth interviews or focus groups with
HIV prevention, treatment and care for collections, the maximum combined healthcare providers are expected to
populations and areas with the greatest number of expected respondents is 600. take 45 minutes to complete.
HIV burden. CDC will communicate In a given year, CDC anticipates that the The total annual response burden
study outcomes to local stakeholders need to screen 1600 persons to identify based on an average of 600 study
and organizations in positions to 800 eligible persons, of which 600 respondents per year (assuming three
consider and implement site-specific persons will agree to participate. large data collections involving 200
improvements in HIV prevention, care, CDC anticipates that screener forms participants each) is estimated at 918
and treatment for each of the study sites will take five minutes to complete each, hours. There is no cost to respondents
examined. For stakeholders, contact information forms will take one other than their time.
Average
Number of
Number of burden per
Type of respondents Form name responses per
respondents response
respondent (in hours)
General Public—Adults ................................... Study Screener .............................................. 1600 1 5/60
General Public—Adults ................................... Contact Information Form .............................. 600 1 1/60
General Public—Adults ................................... Consent Form ................................................ 600 1 5/60
General Public—Adults ................................... Demographic Survey ...................................... 500 1 15/60
General Public—Adults ................................... Interview Guide .............................................. 500 1 1
General Public—Adults ................................... Provider Demographic Survey ....................... 100 1 15/60
General Public—Adults ................................... Provider Interview Guide ................................ 100 1 45/60
Jeffrey M. Zirger, a proposed and/or continuing change, all relevant comments to
Acting Chief, Information Collection Review information collection, as required by Regulations.gov.
Office, Office of Scientific Integrity, Office the Paperwork Reduction Act of 1995. Please note: Submit all Federal
of the Associate Director for Science, Office This notice invites comment on a comments through the Federal
of the Director, Centers for Disease Control proposed information collection project
and Prevention.
eRulemaking portal (regulations.gov) or
titled ‘‘Surveillance of Nonfatal Injuries by U.S. mail to the address listed above.
[FR Doc. 2018–15526 Filed 7–19–18; 8:45 am] Among On-Duty Law Enforcement
FOR FURTHER INFORMATION CONTACT: To
BILLING CODE 4163–18–P Officers.’’ The purpose of this project is
request more information on the
to collect follow-back telephone
proposed project or to obtain a copy of
interview data from injured and
DEPARTMENT OF HEALTH AND the information collection plan and
exposed law enforcement officers
HUMAN SERVICES instruments, contact Jeffrey M. Zirger,
treated in emergency departments (EDs)
Information Collection Review Office,
Centers for Disease Control and and produce a descriptive summary of
Centers for Disease Control and
Prevention these injuries and exposures.
Prevention, 1600 Clifton Road NE, MS–
[60Day–2018–18APJ; Docket No. CDC– DATES:CDC must receive written D74, Atlanta, Georgia 30329; phone:
2018–0062] comments on or before September 18, 404–639–7570; Email: omb@cdc.gov.
2018. SUPPLEMENTARY INFORMATION: Under the
Proposed Data Collection Submitted Paperwork Reduction Act of 1995 (PRA)
for Public Comment and ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018– (44 U.S.C. 3501–3520), Federal agencies
Recommendations must obtain approval from the Office of
0062 by any of the following methods:
AGENCY: Centers for Disease Control and Management and Budget (OMB) for each
• Federal eRulemaking Portal:
Prevention (CDC), Department of Health collection of information they conduct
Regulations.gov. Follow the instructions
and Human Services (HHS). or sponsor. In addition, the PRA also
for submitting comments.
ACTION: Notice with comment period. requires Federal agencies to provide a
• Mail: Jeffrey M. Zirger, Information 60-day notice in the Federal Register
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY: The Centers for Disease Collection Review Office, Centers for concerning each proposed collection of
Control and Prevention (CDC), as part of Disease Control and Prevention, 1600 information, including each new
its continuing effort to reduce public Clifton Road NE, MS–D74, Atlanta, proposed collection, each proposed
burden and maximize the utility of Georgia 30329. extension of existing collection of
government information, invites the Instructions: All submissions received information, and each reinstatement of
general public and other Federal must include the agency name and previously approved information
agencies the opportunity to comment on Docket Number. CDC will post, without collection before submitting the
VerDate Sep<11>2014 18:06 Jul 19, 2018 Jkt 244001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\20JYN1.SGM 20JYN1](https://thefederalregister.org/doc/83_FR_34729/page/2.svg)
Document Created: 2018-07-20 01:19:29
Document Modified: 2018-07-20 01:19:29
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 83 FR 34589 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR